TTAB Oppositions 91215451

USPTO Oppositions proceeding 91215451, filed 2015-03-18. Status: Terminated.

Proceeding Facts

Proceeding Number	91215451
Type	Oppositions
Status	Terminated
Filing Date	2015-03-18
Last Activity	2018-03-12
Days Active	4076

Parties

Sunesis Pharmaceuticals, Inc. — Defendant
Ipsen Pharma S.A.S — Plaintiff

Plaintiff Marks

ONTELRIQ — Ipsen Pharma S.A.S

Defendant Marks

ONCYTIQ — Sunesis Pharmaceuticals, Inc.

Recent Documents

2018-03-12: TERMINATED — Status
2018-03-12: BD DECISION: DISMISSED W/O PREJ — Decisions
2018-03-09: W/DRAW OF APPLICATION — Withdrawals
2018-01-12: SUSPENDED — Status
2017-12-19: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2017-09-05: SUSPENDED — Status
2017-08-21: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2017-05-24: SUSPENDED — Status
2017-05-22: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2017-03-14: SUSPENDED — Status
2017-02-28: P CHANGE OF CORRESP ADDRESS — Parties
2017-02-23: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2016-11-29: SUSPENDED — Status
2016-11-27: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2016-08-30: SUSPENDED — Status
2016-08-29: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2016-06-07: SUSPENDED — Status
2016-06-03: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2016-03-10: SUSPENDED — Status
2016-03-07: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2015-12-16: SUSPENDED — Status
2015-12-09: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2015-09-16: SUSPENDED — Status
2015-09-11: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2015-06-17: SUSPENDED — Status
2015-06-15: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2015-03-26: SUSPENDED — Status
2015-03-18: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
2014-12-19: SUSPENDED — Status
2014-12-19: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions

Related